Quick answer
EHL BIO, represented by Chairman Lee Heung-ki, joined the Korean Peninsula Culture Strategy Forum to discuss medical cooperation and medical tourism promotion between Korea and Thailand based on EHL team assessments.
Key takeaways
- EHL BIO was the only biotechnology company invited to participate as a key panelist in this high-level forum.
- Discussions covered support policies and opportunities for expanding advanced medical services between Korea and Thailand.
- Focusing on building cooperation networks aimed at recovery and improved quality of life.
EHL BIO's Milestone on the International Stage
On May 25, 2022, Chairman Lee Heung-ki of EHL BIO was honored as a keynote speaker at the 'Korean Peninsula Strategy Forum' held at The Westin Josun Seoul. This invitation was highly significant as EHL BIO was the sole biotechnology firm selected to join the discussion among policy leaders.
EHL BIO's role at the event was to present a vision for regenerative medicine and the application of stem cell technology to enhance the quality of life. This aligns with the strategic cooperation between Korea and Thailand to build strong cooperation networks through cutting-edge medical innovation as assessed by the EHL team.
Expanding Medical Networks to Thailand
During the discussion, Chairman Lee Heung-ki addressed key opportunities for expanding international medical service cooperation, focusing on Thailand, a region with high growth potential, showing significant interest in EHL BIO's GMP-standard cell culture technology.
This exchange focused on support policies and the promotion of medical tourism, enabling patients to access stem cell and immune cell care under South Korea's Advanced Regenerative Bio Act, which is an international standard for regulating modern regenerative medicine aimed at quality of life.
EHL BIO is committed to integrating medical technology with cooperation between Korea and Thailand for the goal of recovery and a better quality of life.
Recognized Innovation Standards
The trust EHL BIO garnered stems from its robust foundation in research and development. The company operates GMP-standard research institutes and cell processing centers, being the first in Korea to be authorized as a Human Cell Management Business. Expertise in isolating and culturing cells efficiently makes the company's technology ready for international services.
Furthermore, EHL BIO maintains a network of over 100 partner hospitals in Korea and has expanded cooperation to Thailand. Participating in this strategic forum marks a major step toward expanding service bases and establishing new academic collaborations for future recovery goals.
Service Procedures for Thai Participants
For those interested in services from EHL BIO in Korea or through its partner network, EHL Thailand provides a dedicated Thai coordination team to facilitate every step. This begins with submitting a consultation via the website, where doctors conduct a detailed preliminary review of health records to plan appropriate travel and care for each individual.
Upon arrival at EHL Cell Clinic in Seoul, participants undergo check-ups and tissue sampling for culture in laboratories under strict international quality control. A research team closely monitors the production process before proceeding with the planned services and providing continuous follow-up care once returning to Thailand.
Frequently asked questions
What was the purpose of this strategic forum?
To discuss cultural and medical cooperation between South Korea and Thailand, with EHL BIO invited as a representative of the biotechnology sector.
What are the recovery goals and quality of life focuses of EHL BIO?
EHL BIO focuses on using stem cell technology for physical recovery and enhancing the quality of life of participants, as assessed by the EHL team through cooperation networks in Korea and Thailand.
Why is EHL BIO's GMP standard important?
It promotes quality and safety in cell production, using technology that maintains excellent cell efficiency according to EHL team assessments.
Related conditions
Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.
